TradingView
RocketTickers
2021년 10월 11일 오후 5시 19분
Enzyvant Receives FDA Approval for RETHYMIC® (allogeneic process
NYSE:MYOV
설명
⋅
2021년 10월 11일 오후 5시 19분
MYOV: Enzyvant
2021-10-09 20:09:51
Enzyvant Receives FDA Approval for RETHYMIC® (allogeneic processed thymus tissue-agdc), a One-Time Regenerative Tissue-Based Therapy for Pediatric Congenital Athymia
Beyond Technical Analysis
더보기